Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sixuan Wu
Institutions:
First Affiliated Hospital of University of South China,
University of South China
Observed institutions:
Fujian Medical University,
First Affiliated Hospital of University of South China,
Fujian Provincial Cancer Hospital,
University of South China
ORCID:
0009-0004-9377-4511
Observed ORCID:
0009-0004-9377-4511
OpenAlex ID:
A5110778369
CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation
2024
·
Junfan Pan
, Sixuan Wu
, et al.
·
Cell Death and Disease
·
13
PDF
Unveiling diagnostic biomarkers and therapeutic targets in lung adenocarcinoma using bioinformatics and experimental validation
2025
·
Sixuan Wu
, Yuanbin Tang
, et al.
·
Scientific Reports
·
6
Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment
2026
·
Sixuan Wu
, Bowen Tang
, et al.
·
Human Genomics
·
2
Integration of Machine Learning, Bioinformatics, and Experimental Validation to Identify Novel Diagnostic and Prognostic Biomarkers Associated With Succinylation in Lung Adenocarcinoma
2025
·
Sixuan Wu
, Junfan Pan
, et al.
·
Drug Development Research
·
2
Correction: CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation
2024
·
Junfan Pan
, Sixuan Wu
, et al.
·
Cell Death and Disease
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
24
H-index:
2
I10-index:
1
Year
Topic
Type